Introduction
Examination of bone marrow biopsy specimens is a valuable diagnostic procedure in patients with known or suspected lymphoproliferative disorders. ' A bone marrow biopsy specimen may be diagnostic in patients without lymphadenopathy or when there is no conclusive histological evidence from other sites. In some conditions, such as hairy cell leukaemia,2 it is the primary diagnostic procedure. Bone marrow biopsy is mandatory for staging lymphomas and useful in monitoring treatment. 3 Valuable information on the state of haematopoiesis and changes in stromal components is also provided by trephine biopsy specimens. 4 Bone marrow biopsy specimens are especially important in the staging of Hodgkin's disease, because pathology in the marrow indicates systemic disease and an unfavourable prognosis,5 6 and they are of confirmed value in histological staging and grading of multiple myeloma where histology has been shown to be more accurate than aspiration cytology for quantifying tumour It is our experience that adequate morphology is obtained from formalin fixed, decalcified, and paraffin wax embedded trephine biopsy specimens and that this technique is of particular value for characterising and differentiating neoplastic lymphoid cell populations in the bone marrow using immunohistochemistry (fig 2) . It is especially useful in distinguishing between reactive and neoplastic B lymphocytic aggregates and between minimal disease caused by multiple myeloma and reactive plasmocytosis (fig 3) . Lymphocytes in normal bone marrow Normal bone marrow may contain up to 25% of lymphocytes which are either diffusely dispersed or in the form of nodular aggregates. 26 Benign lymphocytic aggregates are a relatively common finding and are increased according to sex, age, and certain diseases.28 If reactive lymphocytic aggregates are very large (> 0-6 mm in diameter) or numerous (more than four in a standard 1 cm trephine), the term "nodular lymphoid hyperplasia" is used.29 Recognition of benign lymphocytic aggregates is frequently possible as they are usually small and contain a polymorphous cell population within a delicate network of reticulin fibres. They have well defined borders and are distributed at random in the marrow. 30 Lymphocytic nodules of various sizes are suspicious for lymphoma especially if they are peritrabecular, located around a large sinus, or contain fat cells.3' However, a clear distinction between reactive lymphocytic aggregates and lymphocytic lymphoma, or even between leukaemia and lymphoma, may not always be possible by morphology alone (fig 4) , and immunohistochemical investigations are required for definitive diagnosis.3132
Non-Hodgkin's lymphoma A considerable range of positive staging biopsy X, o ' . t A ::w *<-f-ow lymphoma, the most noticeable increase is seen in hairy cell leukaemia. 44 The extent of tumour cell burden is also of important prognostic value.' Without regard to subtype, the median survival in patients with less than 20 volume per cent non-Hodgkin's lymphoma metastasis in the marrow is 73 months; it decreases to 24 months with more than 50 volume per cent. 45 The extent of tumour burden in our series is shown in whereas fibrosis, which can be detected in about 10% of patients with multiple myeloma, is of no prognostic value. 47 Multiple myeloma may involve the marrow in a nodular, interstitial, nodular/interstitial, patchy or dense form.748 A significant correlation has been found between osteoclastic activity, the presence of lytic bone lesions, and the extent of the plasma cell infiltrate. 49 In cases with minimal involvement differential diagnosis from exu- Table 3 72  0  15  43  17  0  Dense  14  25  34  10  17  28  39  70  43  50  50   Total No of cases   66  76  71  32  30  18  18  13  7  6  4 Key: NC = not further classified; Ly = lymphocytic lymphoma (B-CLL); IC = immunocytic; CBCC = centroblastic-centrocytic; HCL = hairy cell leukaemia; pT = peripheral T cell; LB = lymphoblastic; EB = immunoblastic; CB = centroblastic. 
Conclusions
In too many histopathology laboratories the bone marrow trephine biopsy specimen is the Cinderella of histology specimens. Poor fixation and thick sections render them worthless either for evaluation of haematological disease or as an aide to the diagnosis and management of lymphoproliferative disorders. Bone marrow trephine biopsy specimens are an integral part of the diagnosis, staging, and follow up of patients with lymphoproliferative disorders. To obtain optimal value from this procedure good morphology and the availability of immunohistochemical techniques are essential.
